In contrast to CD8+ T cells, there was only a modest but not statistically significant increase in PD-1 expression on CD4+ T cells within the tumor following HER2-DC1 vaccination compared to untreated control (Figure 4C). The gene discussed is ERBB2; the disease is neoplasm.